ALEMBICLTDNSEAlembic Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 18 May · 16:15 IST

Chirayu Amin has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

ALEMBICLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.4%1-day move
₹88.51
prior close
₹88.55
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.2+0.6+1.5+1.5-1.4-1.2-1.1-0.6-0.1-0.8-2.8+1.9+2.3
Up moveDown movePending
AI summary

Promoter Chirayu Amin has filed a declaration with NSE and BSE confirming that neither he nor the 33 persons/entities acting in concert (PACs) have created any encumbrance (pledge, lien, or similar restriction) on Alembic Limited shares during FY 2025-26. The filing lists 34 entities in the promoter group, including companies like Nirayu Private Limited, Shreno Limited, Paushak Limited, and family members including Malika Chirayu Amin and Pranav Chirayu Amin. This is a routine regulatory compliance filing under SEBI's substantial acquisition regulations.

Likely market impact

The declaration that no shares are pledged is a positive indicator for minority shareholders, as it suggests the promoter group has not leveraged their shareholding for debt. This reduces the risk of sudden selling pressure that can occur when pledged shares are invoked.